Inactivation of AR/TMPRSS2-ERG/Wnt signaling networks attenuates the aggressive behavior of prostate cancer cells.
about
Wnt signaling pathways in urological cancers: past decades and still growingPerspectives on new synthetic curcumin analogs and their potential anticancer propertiesRecent progress on nutraceutical research in prostate cancer.Loss of PTEN is associated with aggressive behavior in ERG-positive prostate cancerNetwork modeling of CDF treated pancreatic cancer cells reveals a novel c-myc-p73 dependent apoptotic mechanism.Ring-substituted analogs of 3,3'-diindolylmethane (DIM) induce apoptosis and necrosis in androgen-dependent and -independent prostate cancer cells.The endothelial transcription factor ERG promotes vascular stability and growth through Wnt/β-catenin signaling.Antioxidant function of isoflavone and 3,3'-diindolylmethane: are they important for cancer prevention and therapy?Down-regulation of miR-221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, p27(kip1), p57(kip2), and PUMA.Advances in androgen receptor targeted therapy for prostate cancerInclusion complex of novel curcumin analogue CDF and β-cyclodextrin (1:2) and its enhanced in vivo anticancer activity against pancreatic cancer.Androgen receptor and gene network: Micromechanics reassemble the signaling machinery of TMPRSS2-ERG positive prostate cancer cells.Wnt and SHH in prostate cancer: trouble mongers occupy the TRAIL towards apoptosis.The Multifaceted Roles of STAT3 Signaling in the Progression of Prostate Cancer.Function of phosphorylation of NF-kB p65 ser536 in prostate cancer oncogenesis.miRNAs as drivers of TMPRSS2-ERG negative prostate tumors in African American men.Molecular docking and inhibition of matrix metalloproteinase-2 by novel difluorinatedbenzylidene curcumin analog.The Essential Transcriptional Function of BRD4 in Acute Myeloid Leukemia.The prognostic significance of combined ERG and androgen receptor expression in patients with prostate cancer managed by androgen deprivation therapy.Hypermethylation-mediated transcriptional repression of TMPRSS2 in androgen receptor-negative prostate cancer cells.
P2860
Q21245761-A9E99299-751E-4018-9454-7FC9A6A2AE54Q26851248-2C281B15-4389-4E4C-A423-2F033951E1ACQ33818800-A8DA0BCB-2329-4955-A316-EB7723925348Q33862890-2B06DC86-5678-41D6-87E6-5614DA847C21Q34632154-DAD1EB06-3C15-4271-AC0F-9819195480ECQ34741141-3AEAEF72-C05A-47C7-8862-1E1EE9CA3682Q34939997-96D0071E-73B1-475E-92ED-F01920277E49Q36945706-CFF13A68-B8A4-4D85-897B-FB0D1B0AFDB0Q37278413-4EDAFFA5-DA82-4F10-8C74-6404E8783914Q37337217-D298F688-51D5-48E5-BFEF-34E51A3DB43CQ37405648-5FD6CB00-E171-4F2A-9214-BE0DB0C02EFBQ37727814-1738BFF0-E53B-4782-8CF8-DD98DB273868Q37942610-FB651F36-A5CB-4375-85B3-C73C80E2CF14Q38203779-9A8D26D4-F213-4A5F-A4E8-F38CC60610F9Q38902498-33B9B5F9-7FAB-493E-B9C9-8E6DBE5CFCA7Q39214638-A68DBC1E-61CA-47FF-B820-27AC2C33805CQ39686250-A2EE66C0-A777-456B-8388-4FBAA8B0A191Q41330428-61CB6B15-D427-4F3D-970D-A84C1E96F83FQ42782654-3FE68789-F62B-4BA9-8264-50F5B34258BBQ45753064-CF3ED7F8-77ED-457A-8FEE-D1465FEC765D
P2860
Inactivation of AR/TMPRSS2-ERG/Wnt signaling networks attenuates the aggressive behavior of prostate cancer cells.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Inactivation of AR/TMPRSS2-ERG ...... vior of prostate cancer cells.
@ast
Inactivation of AR/TMPRSS2-ERG ...... vior of prostate cancer cells.
@en
type
label
Inactivation of AR/TMPRSS2-ERG ...... vior of prostate cancer cells.
@ast
Inactivation of AR/TMPRSS2-ERG ...... vior of prostate cancer cells.
@en
prefLabel
Inactivation of AR/TMPRSS2-ERG ...... vior of prostate cancer cells.
@ast
Inactivation of AR/TMPRSS2-ERG ...... vior of prostate cancer cells.
@en
P2093
P2860
P1476
Inactivation of AR/TMPRSS2-ERG ...... vior of prostate cancer cells.
@en
P2093
Aamir Ahmad
Dejuan Kong
Fazlul H Sarkar
Subhash Padhye
Zhiwei Wang
P2860
P304
P356
10.1158/1940-6207.CAPR-11-0077
P577
2011-06-16T00:00:00Z